shortagewatch

Home / Companies / Natco

Company family

Natco: medicine shortages

As of 2 Nov 2026, 22 Natco products have a reported shortage across 1 countries, covering 12 medicines.

Products short22rank #100 of 464
Medicines12active ingredients
Countries1/16
New in 90 days00 vs market pace
Typical duration21 monthsmedian so far
Manufacturing41%demand-driven 5%

Where

Canada22

Which therapeutic classes

Nervous system9Cancer and immune system6Respiratory system3Cardiovascular system2Digestive tract and metabolism1Anti-infectives1

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
NatcoNatco: Manufacturing problem 9 (41%)41%Natco: Increased demand 1 (5%)5%Natco: Other 12 (55%)55%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

When its current shortages began

01235Dec: 0Jan ’25: 0Feb: 0FebMar: 0Apr: 5May: 0MayJun: 0Jul: 3Aug: 1AugSep: 0Oct: 0Nov: 0NovDec: 1Jan ’26: 0Feb: 0FebMar: 0Apr: 1May: 0MayJun: 0Jul: 0Aug: 0AugSep: 0Oct: 0Nov: 0Nov

Long-run trend in Canada

Canada dashboard
061218252018: 5520182019: 101020192020: 3320202023: 1120232024: 252520242025: 131320252026: 112026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Natco22

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Sun Pharma: 250 / 77Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Natco: 22 / 12Natco

Further right: more products short. Higher: more different medicines affected.

Medicines short

MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Donepezil313 Jun 2024Manufacturing problem8/16
Erlotinib31 Dec 2020Other5/16
Levetiracetam38 Apr 2025Manufacturing problem9/16
Montelukast330 Apr 2024Other13/16
Bosentan218 Nov 2024Other7/16
Rizatriptan24 Apr 2025Other6/16
Eribulin121 Aug 2025Manufacturing problem2/16
Gefitinib14 Apr 2025Other2/16
Omeprazole113 Jun 2024Manufacturing problem8/16
Oseltamivir131 Dec 2025Increased demand4/16
Pregabalin117 May 2023Other11/16
Sunitinib113 Apr 2026Manufacturing problem5/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.